|
table 2
Transjugular Intrahepatic Portosystemic Shunt Versus
Endoscopic Sclerotherapy for the Prevention of Variceal Bleeding in
Cirrhosis: A Randomized Multicenter Trial
|
table 2.
Rebleeding
|
|
|
|
Total |
Sclerotherapy |
TIPS |
|
| Patients |
N° |
81 |
43 |
38 |
| Rebleeding |
|
| Patients free of bleeding |
N° (%) |
48 (59.3) |
20 (46.5) |
28 (73.7) |
| Patients rebleeding |
N° (%) |
31 (38.3) |
22 (51.2) |
9 (23.7) |
| Lost to follow-up |
N° (%) |
2 (2.4) |
1 (2.3) |
1 (2.6) |
| Total rebleeding episodes |
N° |
53 |
41 |
12 |
| Rebleeding site |
|
| Esophageal varices |
N° (% of bleeds) |
35 (66.0) |
28 (68.3) |
7 (58.3) |
| Esophageal ulcer |
N° (% of bleeds) |
5 (9.4) |
5 (12.2) |
0 |
| PHG |
N° (% of bleeds) |
2 (3.8) |
2 (4.9) |
0 |
| Other |
N° (% of bleeds) |
6 (11.3) |
3 (7.3) |
3 (25.0) |
| Unknown |
N° (% of bleeds) |
5 (9.5) |
3 (7.3) |
2 (16.7) |
|
|
Return To
Article
table Of Contents
|
